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Guinea pigWe reported previously that the guinea pig cytomegalovirus (CMV) stock purchased from the American Type
Culture Collection contained two types of strains, one containing and the other lacking a 1.6 kb locus, and
that the 1.6 kb locus was required for efﬁcient viral growth in animals but not in cell culture. In this study, we
characterized the genetic contents of the locus, and found that i) the 1.6 kb locus encodes homologs of
human CMV UL128 and UL130, GP129 and GP131, respectively, ii) these genes are expressed with late gene
kinetics, iii) GP131 protein (pGP131) localized to cell surface only in the presence of glycoproteins H and L,
and iv) pGP131 is a virion component. Therefore, it is plausible that pGP131 forms a complex with
glycoproteins H and L and becomes a virion component as does UL130 protein (pUL130). Since pUL130 is one
of the glycoproteins essential for infection of endothelial and epithelial cells in human and primates,
functional and immunological analyses of this GPCMV homolog of pUL130 may help to illuminate the in vivo
role of pUL130.© 2009 Elsevier Inc. All rights reserved.Introduction
Human cytomegalovirus (HCMV) is the most common cause of
congenital virus infection. Congenital infection occurs in 0.2–1% of all
births, and causes birth defects and developmental abnormalities,
including sensorineural hearing loss (SNHL) and developmental delay
(Koyano et al., 2009; Ogawa et al., 2007; Pass, 2001). Animal models
are generally valuable for understanding pathogenesis as well as
developing therapeutics for infectious diseases. In contrast to murine
CMV (MCMV) and rat CMV (RCMV), guinea pig CMV (GPCMV) crosses
the placenta and causes infection in utero. This makes GPCMV animal
models useful for studies on the mechanisms of transplacental
transmission of CMV as well as for evaluation of vaccines, antiviral
drugs, and passive antibody to prevent congenital CMV diseases
(reviewed in Schleiss, 2006; Kern, 2006). We demonstrated con-
genital CMV-associated labyrinthitis in a guinea pig model in which
vertical infection by GPCMV occurred through the placenta (Katano et
al., 2007). During the characterization of GPCMV genome structure,matsu University.
ll rights reserved.we noticed that the GPCMV stock purchased from the American Type
Culture Collection (ATCC) is a mixture of two strains, one containing
and the other lacking a 1.6 kb locus, designated as GPCMV/full and
GPCMV/del, respectively (Nozawa et al., 2008). Importantly, the 1.6 kb
locus was required for efﬁcient viral growth in animals but not in cell
culture. Based on the location of the locus and aweak similarity of one
of the ORFs in the locus with HCMV UL130, we hypothesized that the
locus may correspond to the HCMV locus encoding UL128–UL131A.
Endothelial cells and leukocytes may play an important role in
dissemination of HCMV in vivo, and viral replication in such cells is
likely to contribute to HCMV pathogenesis (Gerna et al., 2004; Grundy
et al., 1998). It is well known that passages of HCMV isolates in
ﬁbroblast cells results in the loss of growth ability in epithelial and
endothelial cells. Several studies demonstrated that the growth defect
was associated with genetic alterations, including ORF-disrupting
mutations and deletions, in the UL128–150 region (Dolan et al., 2004;
Cha et al., 1996; Murphy et al., 2003). It has been reported that UL128,
UL130 and UL131A in the locus are essential for infection of
endothelial and epithelial cells, and also for viral transmission to
leukocytes (Adler et al., 2006; Wang and Shenk, 2005a, 2005b;
Ryckman et al., 2006; Hahn et al., 2004). These genes encode
glycoproteins that form a complex with glycoproteins H (gH) and L
Table 1
Differences in the GPCMV sequences.
This study Schleiss et al. (2008) Effects
Position Sequence Position Sequence
1 188,197
143 A 188,339 AA IE2 exon 5 frame shift
255 C 188,452 T IE2 aa substitution
447 A 188,644 T IE2 aa substitution
1038 G 189,235 GG IE2 exon 5 frame shift
2365 G 190,563 T IE1 aa substitution
2575 T 190,774 G IE1 aa substitution
2728 G 190,927 T IE1 aa substitution
2737 G 190,936 GG IE1 exon 5 frame shift
2879 G 191,079 A Silent
2931 G 191,131 A IE1 aa substitution
2966 A 191,176 AT IE1 exon 5 frame shift
2968 TG 191,078 AT IE1 aa substitution
3758 T 191,958 G Silent (intron)
8701 T 196,901 TGAATAAAACT GP129 exon 3 frame shift
8908 TTGTT 197,118 T GP129 exon 3 frame shift
9134 Ta 197,340 G Silent (intron)
12,920 201,126
a G in a part of ATCC-derived virus stocks.
100 S. Yamada et al. / Virology 391 (2009) 99–106(gL) (Ryckman et al., 2008b) and localize in virion particles (Wang
and Shenk, 2005b).
In this study, we characterized the genetic contents in and in the
vicinity of the 1.6 kb locus, and found that GPCMV encodes biologically
similar orthologs of HCMV UL128 and UL130.Fig.1. (A) Transcription units identiﬁed by RACE in the 13 kb region of GPCMV. The 1.6 kb locu
coding and coding regions are indicated as open and closed boxes/arrows, respectively. ORFs
in parentheses. Probes A to C were used for the Northern blotting analysis. (B) Phylogenic
rhesus CMV (RhCMV), simian CMV (SCMV), and tupaia herpesvirus 1 (THV1). GenBank a
AY186194, U38308, and AF281817, respectively. (C) Northern blotting analysis of the 1.6 k
harvested at the indicated times after inoculation were analyzed. Open and closed arrowhe
(Invitrogen) was used.Results
Comparison of the sequences containing the major immediate-early
genes and the 1.6 kb locus between GPCMV passaged in tissue culture
and that grown in animals
The complete genome sequence of GPCMV that was derived from
the ATCC stock and cultured in vitro was recently reported (Schleiss et
al., 2008). However, i) no HCMV UL123 (IE1) homolog was identiﬁed
in their sequence, ii) the sequence of the open reading frame (ORF)
annotated for UL122 (IE2 exon 5) is different from that previously
reported by us (Nozawa et al., 2008), and iii) it is well known that
human and rhesus cytomegaloviruses cultured in vitro accumulate
genetic alterations in the UL128–UL131A locus. Therefore, from a
collection of four GPCMV strains that differ in their in vivo and in vitro
passage histories, we determined the DNA sequences of a 13 kb
genomic segment that spans the major immediate-early gene locus
and the locus that potentially corresponds to UL128–UL131A. Each of
the four virus strains studied grew efﬁciently in animals. They include:
i) a virus stock passaged in vitro ﬁve times from the original ATCC
stock in GPL cells (TC-P5), ii) a supernatant of sonicated salivary
glands from a guinea pig that was sacriﬁced 21 days after the
inoculationwith GPCMV (SG-P0), iii) a virus stock passaged 5 times in
vitro after infection of GPL cells with the SG-P0 stock (SG-P5), and iv)
one GPCMV/full virus stock that was passaged 5 times in vitro after
virus cloning from a stock obtained from ATCC (CD-P5). The sequence
of SG-P0 and the published sequence had signiﬁcant differences ass essential for efﬁcient growth in vivo is shown as a hatched box on top of the scale. Non-
for which transcripts were not detectable in the Northern blotting (panel C) are shown
dendrogram of IE1 exon 5, including MCMV, RCMV, chimpanzee CMV (CCMV), HCMV,
ccession numbers of these sequences were U68299, AF232689, AF480884, AY446894,
b region. RNA samples prepared from GPL cells that were infected with GPCMV and
ads indicate the GP129 and GP131 transcripts. As size standards, 0.5–10 kb RNA ladder
Table 2
Transcripts and ORFs identiﬁed by RACE analysis.
Gene name Transcript ORF
Start End Start Stop
IE1/2 TATAa 5324
Exon 1 5295 5120
Exon 2 4942 4799
Exon 3 3631 3518 3630
Exon 4 3428 3196
IE1 (GP123b) Exon 5 3108 1860 2030
polyAa 1882
IE2 (GP122) Exon 5 1818 8 134
polyAa 34
GP128b TATAa 6845
Exon 1 6875 6948
Exon 2 7516 8784 7638 8693
polyAa 8764
GP129 TATAa NA
Exon 1 9418 9210 9364
Exon 2 9131 9006
Exon 3 8928 7056 8670
polyAa 7071
GP130 TATAa 8593
Gene 8623 9584 8893 9285
polyAa 9552
GP131 TATAa 10,457
Exon 1 10,424 9786 10,027
Exon 2 9705 9364 9369
polyAa 9430
GP134 TATAa 12,080
Gene 12,048 10,417 11,187 10,504
polyAa 10,445
1.6 kb deletion 8847 10,495
a First base of the TATA box and polyA signal is indicated.
b Designated based on the homology with M128 and R128, although it was described
as GP123 recently (Schleiss et al., 2008).
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without the 1.6 kb deletion as we reported previously and it had a
sequence of both G and T at position 9134. However, the remaining
part was identical with SG-P0. Importantly, SG-P5 and CD-P5 were
identical with SG-P0. Therefore, the differences with the published
sequence might be due to differences in in vitro passage history or to
sequencing a particular virus cloned as a BAC.
Gene organization
We reported the IE2 gene structure and demonstrated the
expression of the IE2 transcript previously (Nozawa et al., 2008). In
this study we extended the analysis of GPCMV genetic content andFig. 2. Detection and quantiﬁcation of GP129 and GP131 transcripts by quantitative RT-PCR
harvested at the indicated times after infectionwere used for the assays. S7, S9, and S10 (Supp
transcripts, respectively. The amounts of the GP131 and GP129 transcripts relative to that of
numbers. (B–D) RNA samples prepared from liver, lung, and spleen of guinea pigs infected w
of the GP131 and GP89 transcripts were calculated based on threshold PCR cycle numbers, a
transcripts per mg of the organs in the assay was deﬁned as 1.gene expression to the 13 kb region described above. For this purpose,
we performed 5′ and 3′ RACE experiments using various primers. We
identiﬁed ﬁve transcription units in addition to IE1 and IE2
transcription units (Fig. 1A). The details of the intron/exon structures
and potential TATA-boxes and poly(A) signals are summarized in
Table 2. The predicted differences in protein coding potential between
the published GPCMV sequence and the sequences we determined for
the SG-P0, SG-P5, and CD-P5 viruses are summarized in Table 1.
Notably, the two sequences lead to signiﬁcant changes in the
predicted amino acid sequences. For example, the frame shift
alterations at positions 188,339 and 189,235 in the published
sequence disturb the coding contents of IE2 exon 5 (GP122). Similarly,
the insertions at 190,936 and 191,176 made identiﬁcation of GP123, a
homolog of IE1 (UL123), impossible in the published sequence. In our
sequences, GP123 was recognizable as IE1 exon 5 with unambiguous
homology with MCMV M123, RCMV R123-EX4, RhCMV Rh156, THV1
t123 and HCMV UL123. Their amino acid (a.a.) sequence similarities
are 56, 56, 57, 57 and 59%, respectively. Phylogenetic analysis of IE1
places GPCMV at similar distances between rodent and primate CMVs,
as observed previously for IE2 (Fig. 1B). Based on the designations for
orthologous genes in other CMVs, we designate IE1 exon 5 as GP123
and a homolog of MCMVM128 as GP128. Although these designations
differ from those used in the report of the complete GPCMV genome
sequence (Schleiss et al., 2008), the sequences of M128 homolog in
both studies are exactly same.
Expression of GP129 and GP131 at the RNA level in vitro and in vivo
To exclude the possibility that RACE reactions ampliﬁed some
artifactual products, expression of the transcription units for GP129,
GP130, GP131 and GP134 was analyzed by Northern blotting. Probe
A, which can theoretically detect all four of these transcripts,
detected at least two transcripts of 2.8 kb (open arrowhead) and
1.2 kb (closed arrowhead) (Fig. 1C). Based on the lengths of the
transcripts and additional information obtained from Probes B and
C, the 2.8 kb and 1.2 kb transcripts are likely to be the transcripts for
GP129 and GP131, respectively. Both transcripts were detectable
from 24 h post infection. The transcripts were not detected after
treatment of the infected cells with phosphonoacetic acid (PAA)
(data not shown), suggesting that both GP129 and GP131 are late
genes. The transcripts corresponding to GP130 and GP134 were not
detectable in the blots.
To conﬁrm the expression of GP129 and GP131 during the lytic
growth phase of GPCMV infection, quantitative RT-PCR assays for
detection of their transcripts were performed using probes S7 and S9
that targeted the splicing junctions (Supplementary table 1, Fig. 2A).assays. (A) RNA samples prepared from GPL cells that were infected with GPCMV and
lementary table 1) were used as a set of primers/probe for the GP131, GP129 and β-actin
the β-actin transcripts were calculated based on differences in the threshold PCR cycle
ith GPCMV/full (closed circles) and with GPCMV/del (open triangles). Relative amounts
nd normalized with weights of organs used for RNA preparation. Detection limit of the
102 S. Yamada et al. / Virology 391 (2009) 99–106In GPL cells, GP131 transcript levels increased signiﬁcantly from 24 h
post infection, while the GP129 transcripts accumulated gradually.
The abundance of GP131 transcripts was N100-fold greater than for
GP129 at 3 days post infection.
GP131 transcripts were expressed also in the livers and spleens of
guinea pigs infected with GPCMV/full (Fig. 2B). Transcripts of the
GP89 gene encoding a late gene product, terminase, were detected
in the animals infected both with GPCMV/full and with GPCMV/del
(Fig. 2C). The amounts of the GP131 and GP89 transcripts in the
GPCMV/full-infected animals showed a correlation (Fig. 2D).Fig. 3. Amino acid sequence homology of GP129 and GP131 with UL128 and UL130 hom
highlighted in gray, respectively. GenBank accession numbers of sequences used for comp
22659) EU130540, SCMV U38308, and HCMV (Merlin) AY446894. UL128 sequences of CCM
previous report (Akter et al., 2003). The core region of HCMV UL128 crucial for endothelia
Arrowheads indicate the splice junctions in each ORF. Hydrophilicity/hydrophobicity plots of
method of Hopp and Woods (1981). Areas above and below indicate hydrophilic and hydrop
sites of HCMV and GPCMV, and two plots were matched at the sites. The horizontal scale inRelationships among amino acid sequences of GP129 and GP131 with
HCMV UL128 and UL130
The a.a. sequence of GP129 has 33% identity and 48% similarity
with HCMV UL128 (Fig. 3). Very recently, a core region of HCMV
pUL128 crucial for endothelial cell tropism has been mapped to a.a.
positions 72 to 106 by charge cluster-to-alanine mutagenesis
(Schuessler et al., 2008). The core region corresponds to the
sequences that are highly homologous to other UL128 homologs,
including GPCMV GP129. Interestingly, the second splicing junctionologs, respectively. Identical and homologous sequences to GPCMV were boxed and
arison of UL128 and UL130 homologs are as follows: CCMV AF480884, RhCMV (strain
V, SCMV and HCMV were corrected to the expected wild-type sequences based on the
l cell tropism (Schuessler et al., 2008) is shown with a closed bar on top of sequences.
the GP129 and GP131 a.a. sequences generated by the software (GENETYX) based on the
hobic domains, respectively. Arrowheads indicate the predicted signal peptide cleavage
dicates the a.a. sequence positions of the GPCMV proteins.
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homologs. The a.a. sequence of the GP131 ORF has 19% identity and
36% similarity with HCMV UL130. A potential N-glycosylation site of
GP131 was predicted at a.a. positions 51–54, around which the
sequences were highly homologous to HCMV UL130 (NetNGlyc 1.0
Server, www.cbs.dtu.dk/services/NetNGlyc/). Both GP129 and
GP131 a.a. sequences posses signal sequences, but not trans-
membrane domains.
No CMV homolog for GP130 and GP134 were identiﬁed in
GenBank. There was no recognizable homolog of HCMV UL131A in
the vicinity of the GP129 and GP131 genes.Fig. 4. Expression of pGP131. (A) GPL cells were infected with GPCMV CD-P5 (full) or CA-P5
anti-GP131 antibody followed by FITC-conjugated anti-rabbit IgG antibody. (B) GPL cells we
and cultured for 48 h. Structures of the plasmids are shown schematically. The cells were rea
cultured for 5 days. Also GPL cells were transfected with pCMV-GP131C, or with a combin
transfected cells were ﬁxed with paraformaldehyde, treated with or without Triton-X100 (
images of the GPL cells that were cotransfected with pCMV-GP131C, -gH/Myc, and -gL/His,
anti-myc antibodies were reacted with FITC- (green) and TRITC- (orange) conjugated secon
transfected with pCMV-Tag4A (vec: lane 1) or with pCMV-GP131C (GP131: lane 2) were im
puriﬁed virion preparations of GPCMV/full (lanes 3 and 4) and GPCMV/del (lane 5) were r
number of viral particles run in each lane was 1×108 based on genome copy number. ArroDetection of pGP131
Because the GP131 transcript is more abundant than the GP129
transcripts, we focused on GP131 in the following analyses. Antibody
against GP131 protein was prepared by immunization of a rabbit with
a partially-puriﬁed GST-GP131 fusion protein. Anti-GP131 detected a
ﬂuorescent signal in the GPL cells infected with CD-P5 (GPCMV/full)
but not CA-P5 (GPCMV/del) (Fig. 4A), indicating the speciﬁcity of the
antibody. Both anti-GP131 (Fig. 4B) and anti-FLAG tag (data not
shown) antibodies detected diffuse signals in cytoplasm of the 293T
and GPL cells that were ﬁxed with acetone 48 h after transfection of(del) stock, and cultured for 5 days. The cells were ﬁxed with acetone, incubated with
re transfected with one of the plasmids, pCMV-GP131B, -GP131C, and -Tag4A (vector),
cted as described for panel A. (C) GPL cells were infected with GPCMV CD-P5 (full) and
ation of pCMV-GP131C, -gH/Myc, and -gL/His, and cultured for 48 h. The infected or
TX) for permeabilization, and then reacted with antibodies. (D) Confocal microscopic
and ﬁxed with paraformaldehyde followed by Triton-X100 treatment. Anti-GP131 and
dary antibodies, respectively. (E) Detection of pGP131 in virions. Extracts of GPL cells
munoprecipitated with anti-GP131 antibody. The precipitated samples and partially-
un on 12% SDS-PAGE and analyzed by immunoblotting with anti-GP131 antibody. The
wheads indicate the pGP131 band.
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hand, in the cells transfected with pCMV-GP131B plasmid, signals
were almost undetectable. A potential 127 a.a. ORF, which can be
identiﬁed just 14 bp from the start site of the same transcript may be
involved in the decrease of pGP131 level.
Cell surface localization of pGP131 in the presence of gH/gL
pGP131 was detected on the surface of GPCMV-infected cells after
paraformaldehyde ﬁxation without permeabilization (Fig. 4C). In
contrast, in cells transfected with pCMV-GP131C, pGP131 was only
detectable after treatment of the paraformaldehyde-ﬁxed cells with
Triton-X100. Importantly, cotransfection of gH- and gL-expressing
plasmids with pCMV-GP131C enabled cell surface expression of
pGP131, suggesting that gH/gL is required for cell surface trafﬁcking
of pGP131.
Co-localization of pGP131 with gH (Fig. 4D) and with gL (data not
shown) was demonstrated by analysis of the cells cotransfected with
pCMV-GP131C, -gH/Myc, and -gL/His in confocal microscopy. These
data suggest that pGP131 forms a complex with gH/gL.
pGP131 is present in virions
pGP131 in GPL cells was immunoprecipitated with anti-GP131
antibody, and then detected as a 20-kD band in immunoblotting with
the same antibody (Fig. 4E, lane 2). Probably due to the small amount
of the protein, enrichment of the protein by immunoprecipitationwas
needed. The same size band was detected with a partially-puriﬁed
GPCMV/full virion sample (Fig. 4E, lanes 3 and 4) but not with
GPCMV/del one (lane 5), indicating that pGP131 is a virion
component. The viral antigen recognized by the monoclonal antibody
g-1 (Katano et al., 2007), which is localized in nuclei of infected cells
but not in virion, was undetectable in the virion preparations used in
this study (data not shown).
Discussion
In this study, we found the following: i) the 1.6 kb locus essential
for efﬁcient in vivo dissemination of GPCMV encodes homologs of
HCMV UL128 and UL130, i.e. GP129 and GP131, respectively, ii) these
genes were expressed with late gene kinetics, iii) expression of
pGP131 on cell surface required co-expression of gH and gL, iv)
pGP131 colocalized with gH and gL, and v) pGP131 is a virion
component. Therefore, it is likely that GPCMV pGP131 has function
similar to pUL130.
From an evolutionary perspective, the GPCMV genome has
chimeric characteristics between rodent and primate CMVs. GPCMV
encodes a homolog of MCMV and RCMV ie2 genes (M128 and R128),
which are not found in primate CMVs. In contrast, GPCMV encodes
homologs of HCMV UL128 and UL130, which are identiﬁed in most
primate CMVs, including chimpanzee, rhesus, and simian CMVs
(Akter et al., 2003; Rivailler et al., 2006); in place of UL128 and
UL130, rodent CMVs encode CC-chemokine-like products, which are
essential for efﬁcient virus growth in vivo (Saederup et al., 1999;
MacDonald et al., 1999; Voigt et al., 2005; Manning et al., 1992).
Curiously, GPCMV apparently does not encode for a homolog of HCMV
UL131A that is considered indispensable for infection of the
epithelial/endothelial/leukocyte cell types (Adler et al., 2006; Hahn
et al., 2004; Ryckman et al., 2008b; Wang and Shenk, 2005a).
Identiﬁcation and characterization of CMVs from animals that are
evolutionarily intermediate from guinea pigs to primates, as well as
from rats to guinea pigs, may contribute to better understanding of
how UL128–131A gene homologs were acquired or created.
Several studies have demonstrated that HCMV pUL128, pUL130
and pUL131A are individually indispensable for infection of endothe-
lial and epithelial cells (Adler et al., 2006; Wang and Shenk, 2005a;Wang et al., 2007; Ryckman et al., 2006). Inefﬁcient growth of RhCMV
68-1, an RhCMV strain lacking UL128 and a part of UL130, in epithelial
cells was overcome by the repair of these genes, and the repaired
RhCMV could grow even in human endothelial and epithelial cells
(Lilja and Shenk, 2008). In our previous study, we demonstrated that
the 1.6 kb locus containing the GP129 and GP131 genes was
indispensable for growth in vivo but not in ﬁbroblast cells in vitro,
and discussed that our study was limited by an absence of
experimental evidence demonstrating expression of GP129 and
GP131 was directly associated with an altered cell tropism. In the
case of GPCMV, the lack of easily available guinea pig endothelial and
epithelial cells as well as of commercial antibodies against particular
cell types of guinea pigs hinders evaluation of GP129 and GP131 for
involvement in cell tropisms. Unfortunately, there is not yet any BAC
system for examination of GPCMV growth in animals, since the
GPCMV-BAC clone initially used for biological analysis by others lacks
the 1.6 kb locus (Schleiss et al., 2008). The recently developed
excisable GPCMV-BAC clone pN13R10 (Cui et al., 2008a) has a 4-bp
deletion in GP129 exon 3 at position 8908 (data not shown), and the
growth of GPCMV recovered from the BAC clone in animals has not
been characterized. Therefore, we still lack a system for in vivo genetic
evaluation of the functions of pGP129 and pGP131.
HCMV pUL128–pUL131A form a complex with gH and gL, and co-
expression of pUL128–pUL131A with gH/gL is required for efﬁcient
transport of gH/gL/pUL128–pUL131A complex from the ER to the
Golgi apparatus and then for extracellular secretion of the soluble
form of the complex (Ryckman et al., 2008b). It was proposed that the
gH/gL/pUL128–pUL131A complex binds to a cell-speciﬁc receptor
(Ryckman et al., 2008a) and that at least pUL128 is directly involved in
the receptor binding (Patrone et al., 2007). Biological similarity of
GPCMV pGP131 with HCMV pUL130 can be assumed based on our
ﬁndings of: i) sequence similarity between GP131 and UL130, ii)
incorporation of pGP131 into virions, iii) cell surface expression of
pGP131 only in the presence of gH and gL, and iv) colocalization of
pGP131 with gH and with gL. However, since the amount of pGP131
expressed in vitro was insufﬁcient for biochemical analysis, further
study will be required to learnwhether pGP131 interacts directly with
gH/gL. Recent studies demonstrated that antibodies against pUL128,
pUL130 and pUL131A neutralized virus infection of endothelial and
epithelial cells and inhibited virus transfer from HCMV-infected cells
to leukocytes (Gerna et al., 2008). Human immune sera have higher
neutralizing activities against epithelial cell entry compared to
ﬁbroblast entry, and epithelial entry-speciﬁc neutralizing activities
induced by the Towne and gB vaccines were lower than those
observed following natural infection (Cui et al., 2008b). These
observations suggest that subunit vaccines based on pUL128,
pUL130 and pUL131A might be effective and could cooperate with
the gB subunit vaccine. For that purpose, analyses in guinea pigs of
immunologic reactions to GPCMV pGP129 and pGP131 may provide
useful insights, since previous studies by us and others (Katano et al.,
2007; Schleiss, 2006) demonstrated that the virus with the 1.6 kb
region, or the salivary grand-passaged virus, crossed the placenta and
infected fetus.
Materials and methods
Cells, viruses, and animals
Guinea pig lung ﬁbroblasts (GPL, ATCC CCL-158) were cultured in
F-12 medium supplemented with 10% fetal bovine serum (FBS), and
after infection with GPCMV, in F-12 medium supplemented with 2%
FBS. GPL cells were infected with GPCMV strain 22122 purchased from
ATCC (VR-682). The infected cells (TC-P1) were propagated by co-
culturing with uninfected GPL cells at a ratio of 1:5–1:10 four times to
prepare a large stock of cell-free virus (TC-P5). Preparation of stocks of
ten independent virus clones (CA-P5 to CJ-P5) was described
105S. Yamada et al. / Virology 391 (2009) 99–106previously (Nozawa et al., 2008). From them, CD-P5 and CA-P5 were
used here as GPCMV/full and GPCMV/del, respectively. GPCMV stocks
were also prepared from salivary glands (SG) of a guinea pig (Hartley
strain) infected with the TC-P5 stock. SG were minced, sonicated
brieﬂy, and then centrifuged to remove debris. These supernatants
(SG-P0) were used for infection of GPL cells, and viral stocks were
prepared after propagation of the cell-free virus 5 times in GPL cells
(SG-P5). Partially-puriﬁed virions were prepared as follows. After
removal of cell debris by centrifugation, supernatants of GPCMV-
infected cells were loaded on a sucrose gradient (30% and 50% sucrose
in PBS) and centrifuged at 82,000 ×g for 2 h. The particles between
the sucrose layers were collected and then precipitated by
centrifugation.
Five-week old female guinea pigs (Hartley, Japan SLC, Inc.) were
inoculated intra-peritonealy (i.p.) with 106 PFU of GPCMV. Blood
specimens drawn directly from heart, and organ specimens,
including liver, spleen, kidney, lung, and salivary gland, were
harvested at indicated days after inoculation. All animal procedures
were approved by the Animal Care and Use Committee of the
National Institute of Infectious Diseases (NIID), and were conducted
according to ‘the Guidelines for Animal Experiments Performed at
the NIID’.
Sequencing
Two 6 to7 kb fragments spanning the 13 kb region of GPCMV were
ampliﬁed by PCR using KOD-FX polymerase (Toyobo, Japan) with
primer sets S1 and S2 (Supplementary table 1), and puriﬁed by using a
commercial kit (QIAEXII, Qiagen). A commercial kit (BigDye Termi-
nator Cycle Sequencing Kit ver. 3.3, PE Applied Biosystems) was used
for sequencing of these fragments, and the reactions were analyzed in
the ABI PRISM 7500 sequence detection system (PE Applied
Biosystems). Data were assembled and analyzed by using the
programs ATGC and GENETYX (Genetyx Inc., Tokyo, Japan). The
13 kb sequence obtained fromGPCMVDNA prepared from the salivary
gland of an infected animal was deposited to DDBJ (accession no.
AB492278).
RACE
GPL cells were infected with GPCMV at a multiplicity of infection
(MOI) of 5, and cultured for 3 days. Total RNA samples were prepared
by using RNeasy Plus Mini kit (Qiagen). The RACE reactions were
done by using a commercial kit (SMART RACE cDNA Ampliﬁcation
Kit, Clontech) as described in the manufacturer's instructions.
Sequences of the RACE products were determined as described
above.
Northern blotting
GPL cells were infected with GPCMV at an MOI of 5, cultured in the
absence or presence of 0.3 mg/ml PAA, and harvested at 6, 10, 24, 48,
and 72 h after infection. 2 μg of total RNA prepared as described above
was run on 1.0 % agarose gels containing formaldehyde and blotted
onto Hybond H+ membranes (GE Healthcare). DNA fragments
prepared by PCR using primer sets S3, S4 and S5 (Supplementary
table 1) were used as probes for hybridization. The hybridized signals
were detected by using a commercial kit (ECL Direct Labeling and
Detection System, GE Healthcare).
Quantitative RT-PCR
Quantitative RT-PCR assays were carried out as described pre-
viously (Nozawa et al., 2008). Primer and probe sets S6-S10 were used
for detection of GP89 (terminase gene), GP131, GP129, and β-actin
transcripts (Supplementary table 1).Construction of plasmids
A fragment was ampliﬁed from overlapping 5′ and 3′ RACE
products for the GP131 gene by PCR using Pfu polymerase (Promega)
with a primer set S11, and cloned between XhoI and NotI sites of
pCMV-Tag4 (Stratagene), resulting in pCMV-GP131A. Fragments
ampliﬁed from pCMV-GP131A with primer sets S12 and S13,
respectively, were cloned into pCMV-Tag4, resulting in pCMV-
GP131B and -GP131C (Fig. 4B). Fragments containing gH and gL ORFs
were ampliﬁed from plasmids of a GPCMV genome library using KOD-
FX polymerase with primer sets S14 and S15, respectively. The gH
fragmentwas cloned into pA3M,which adds threemyc epitope-tags at
the carboxyl-terminus (Aster et al., 1997), resulting in pCMV-gH/Myc,
and the gL fragment into pcDNA6/V5-His (Invitrogen), which adds a
His tag at the carboxyl-terminus, resulting in pCMV-gL/His.
Preparation of antibody against pGP131
A DNA fragment containing a part of GP131 ORF (a.a. position 13 to
192) was ampliﬁed by PCR with a primer set S16 (Supplementary
table 1) and cloned into pGEX-6P-1 vector (GE Healthcare). The GST-
GP131 fusion protein was expressed in BL21 cells (Invitrogen) upon
addition of IPTG. Insoluble inclusion bodies, containing the GST-GP131
fusion protein, were prepared from the cells and solubilized in 8 M
urea. The samples were diluted eight fold with PBS containing 0.5%
Triton-X100 and puriﬁed by glutathione-sepharose column (GE
Healthcare). Finally, a rabbit was immunized with the GST-GP131
fusion protein (Japan Biotest Corporation).
Immunoﬂuorescence assay (IFA)
Transfection of cells was performed by using a commercial reagent
(Fugene 6, Roche). GPCMV-infected and transfected cells were ﬁxed
with acetone for 5 min or with 4% paraformaldehyde for 15 min
followed by treatment with 0.1 % Triton X-100 for 10 min. Anti-GP131
rabbit antibody and anti-myc monoclonal antibody 9E10 (Santa Cruz)
were used as primary antibodies, and FITC-conjugated anti-rabbit IgG
and TRITC-conjugated anti-mouse IgG antibodies were used as
secondary antibodies. Confocal images were captured with a LSM5
PASCAL digital confocal microscope (Zeiss), and analyzed by using its
LSM Image Browser.
Immunoprecipitation and immunoblotting
Transfected or infected cells were incubated in a Lysis buffer
containing 50 mM Tris–HCl (pH 8.0), 150 mM NaCl, 1% NP-40, and
1 mM phenyl-methylsulfonyl ﬂuoride (PMSF) for 20 min. After
centrifugation at 9000 ×g for 15 min, supernatants were recovered
as cell extracts. The extracts were pre-cleared with protein G-
agarose (GE Healthcare) for 1 h and then immunoprecipitated using
anti-GP131 polyclonal rabbit antibody along with protein G-agarose
for 1 h. The resin was washed in the Lysis buffer 4 times. Proteins
bound to the resin were eluted by boiling in 4% SDS and 10% 2-
mercaptoethanol, separated in a 12% SDS-polyacrylamide gel, and
then transferred to a Hybond-P membrane (GE healthcare) for
immunoblotting. Immunoblot reactions were done as described
previously (Koyano et al., 2003).
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